Rotherham, Doncaster and South Humber NHS Foundation Trust patient group director (PGD) for the supply of podophyllotoxin 0.15% weight in weight cream or 0.5% weight per volume solution for the treatment of external anogenital warts PGD.
This patient group direction (PGD) must only be used by registered professionals who have been named and authorised by their organisation to practise under it.
This PGD template has been peer-reviewed by the sexual health PGDs short life working group in accordance with their terms of reference. It was approved by the British association for sexual health and HIV (BASHH) and bacterial special interest group (BSIG) in February 2021.
To access this PGD please follow the link: PGD SH Podophyllotoxin National PGD v2.1.
To access the equality impact assessment for this policy, please see the overarching equality impact assessment.
Page last reviewed: April 30, 2024
Next review due: April 30, 2025